NVAX SEC filing data SEC EDGAR DEF 14A

Novavax Inc CEO pay ratio

SEC EDGAR DEF 14A company record · Chemicals & Pharmaceuticals - structured pay-ratio figures are incomplete for this issuer.

State
DE
Filing date
n/a
Industry
Chemicals & Pharmaceuticals
Fiscal year
n/a

Data updated August 2026

Subscribe to Novavax Inc CEO pay filing updates (RSS)

Structured pay-ratio dollars are incomplete for this CIK. Browse peers via rankings or the industry directory.

Answer first

Novavax Inc is tracked in PlainCEOPay's SEC EDGAR DEF 14A corpus with an incomplete latest pay-ratio extraction (missing CEO total or median-worker pay). Its SIC peers in Chemicals & Pharmaceuticals show a median ratio of 42:1 across 168 FY2025 filers.

Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Pay ratio
n/a
Incomplete filing
CEO total
n/a
Summary Compensation Table total
Median worker
n/a
Dodd-Frank median employee

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

Filing-year trail · Novavax Inc

Complete DEF 14A pay-ratio filings for this CIK across FY2022–2023. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
60:1
FY2023
vs prior FY
-13:1
from FY2022 73:1
CEO $ YoY
-13%
$7.3M latest
Filings shown
2
FY2022–2023
Novavax Inc CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2022 $8.4M - $115,082 73:1 -
2023 $7.3M -13% $122,236 60:1 -13:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1000694, FY2022–2023. Adjacent-year deltas only.

Company Info

Ticker
NVAX
CIK
1000694
Industry
Chemicals & Pharmaceuticals
SIC Code
2836
State
DE
SEC EDGAR DEF 14A for CIK 1000694. Informational only, not investment advice. Verify on EDGAR.

Read with Novavax Inc

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps UNFILED · UNFILED · UNFILED.

Data sourced from SEC EDGAR DEF 14A for Novavax Inc (CIK 1000694). See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.